US Broker Ratings

Zimmer Biomet Holdings, Inc. (ZBH) Stock Analysis: Strong Potential Upside with Robust Analyst Ratings

Zimmer Biomet Holdings, Inc. (NYSE: ZBH), a formidable player in the healthcare sector, specializes in medical devices and boasts a significant market cap of $18.42 billion...

Sarepta Therapeutics, Inc. (SRPT) Investor Outlook: Analyzing the 31.63% Potential Upside

Sarepta Therapeutics, Inc. (SRPT), a prominent player in the biotechnology sector, is capturing the attention of investors with its significant 31.63% potential upside. This commercial-stage biopharmaceutical..

Option Care Health, Inc. (OPCH) Investor Outlook: Analyzing a 20% Upside Potential

Option Care Health, Inc. (NASDAQ: OPCH) stands out in the healthcare sector, particularly within the medical care facilities industry. With a market cap of $3.56 billion,..

Oscar Health, Inc. (OSCR) Stock Analysis: Impressive Revenue Growth and What It Means for Investors

Oscar Health, Inc. (NYSE: OSCR), a prominent player in the healthcare technology sector, continues to catch the eye of investors with its impressive 70.40% revenue growth...

Rhythm Pharmaceuticals, Inc. (RYTM) Investor Outlook: Analyzing a 22.4% Potential Upside for This Biotech Innovator

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM), a key player in the biotechnology sector focusing on rare neuroendocrine diseases, has caught the eye of investors with its innovative..

argenx SE (ARGX) Stock Analysis: Unlocking a 25% Upside in the Biotech Sector

argenx SE (NASDAQ: ARGX), a prominent player in the biotechnology industry, is making waves with its innovative therapies targeting autoimmune diseases. With a market capitalization of..

Bio-Rad Laboratories (BIO) Stock Analysis: Exploring a Potentially Overvalued Healthcare Giant

Bio-Rad Laboratories, Inc. (NYSE: BIO), a formidable player in the medical devices industry, has captured the attention of investors with its stock price soaring to $352.47,..

Zoetis Inc. (ZTS) Investor Outlook: Analyzing a Potential 43% Upside in the Healthcare Sector

Zoetis Inc. (NYSE: ZTS) remains a prominent player in the healthcare sector, specifically within the niche of drug manufacturing for specialty and generic products. With a..

Lantheus Holdings (LNTH): Investor Outlook on Strong Upside Potential and Robust Product Portfolio

Lantheus Holdings, Inc. (NASDAQ: LNTH) has emerged as a formidable player in the healthcare sector, particularly within the niche of specialty and generic drug manufacturing. With..

Glaukos Corporation (GKOS) Stock Analysis: Target Price Insights and Growth Prospects

Glaukos Corporation (NYSE: GKOS), a prominent player in the healthcare sector, specifically within the medical devices industry, has recently captured significant attention from investors due to..

Roivant Sciences Ltd. (ROIV) Stock Analysis: Strong Buy Ratings and 15% Upside Potential

Roivant Sciences Ltd. (NASDAQ: ROIV) is making waves in the biotechnology sector with its promising pipeline of clinical-stage products and innovative delivery platforms. As a United..

Bausch + Lomb Corporation (BLCO): Growth Potential and Analyst Ratings Point to an 11% Upside

Bausch + Lomb Corporation (NYSE: BLCO), a prominent player in the healthcare sector, is attracting investor attention with its potential for growth and strong market positioning...

ICON plc (ICLR)

⚠️ No article content returned.

..

RadNet, Inc. (RDNT) Investor Outlook: Capitalizing on a 23.99% Potential Upside in the Booming Diagnostics Sector

RadNet, Inc. (NASDAQ: RDNT) has been making waves in the healthcare sector, particularly in diagnostics and research. With a market capitalization of $5.69 billion, RadNet stands..

BridgeBio Pharma, Inc. (BBIO) Stock Analysis: Tapping into a 25.70% Potential Upside in the Biotech Sector

BridgeBio Pharma, Inc. (NASDAQ: BBIO), a prominent player in the biotechnology industry, offers a compelling case for investors seeking high-growth opportunities in the healthcare sector. With..

West Pharmaceutical Services, Inc. (WST) Stock Analysis: A 14% Upside Potential with Strong Buy Ratings

West Pharmaceutical Services, Inc. (NYSE: WST) has been making waves in the healthcare sector, specifically within the medical instruments and supplies industry. With a robust market..

Alnylam Pharmaceuticals, Inc. (ALNY) Stock Analysis: Exploring a 71% Potential Upside Amid Strong Revenue Growth

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY), a pioneering biotech firm specializing in RNA interference therapeutics, is capturing investor attention with its robust revenue growth and promising pipeline...

Avantor, Inc. (AVTR) Stock Analysis: Insights into a Healthcare Leader’s Potential Upside

Avantor, Inc. (AVTR), a significant player in the healthcare sector, is garnering attention from individual investors due to its diverse offerings and strategic market position. With..

Krystal Biotech, Inc. (KRYS) Stock Analysis: Exploring a 17% Potential Upside in the Biotech Sector

For investors interested in the booming biotechnology industry, Krystal Biotech, Inc. (NASDAQ: KRYS) presents an intriguing opportunity. With a current market cap of $9.66 billion, this..

Incyte Corporation (INCY) Stock Analysis: Strong Revenue Growth and Robust Pipeline Fuel Investor Interest

Incyte Corporation (NASDAQ: INCY), a prominent player in the biotechnology industry, has captured the attention of investors with its impressive revenue growth and promising therapeutic pipeline...

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds